Not Yet RecruitingNot Applicable

Home-Based Stroke Rehabilitation Using Enriched Environments (PEER-HOMEcare)

Latvia, Norway, Sweden45 participantsStarted 2026-03-15

Plain-language summary

The goal of this clinical trial is to learn whether the PEERHOMEcare intervention is a feasible and acceptable methodology that may have the potential to improve recovery for adults who are recovering from stroke and receiving rehabilitation at home. PEERHOMEcare adapts research on enriched environments to support brain recovery by creating stimulating and supportive home rehabilitation settings and by involving healthcare professionals and family members. The main questions it aims to answer are whether the PEERHOMEcare approach is feasible to implement in home-based stroke rehabilitation in Norway, Sweden, and Latvia, and whether it improves patient engagement and participation in rehabilitation during the first six months after stroke. Researchers will assess the delivery of the PEERHOMEcare approach to see if the intervention is feasible and acceptable and if the educational material can be used to improve engagement and recovery. Participants will receive home-based stroke rehabilitation, work with project therapists and family members to adapt their home environment to support rehabilitation activities, and complete assessments and follow-up visits to measure engagement, upper limb motor recovery, and feasibility of the intervention.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adults (≥18 years old) * diagnosed with first or second haemorrhagic or ischaemic stroke * stroke onset no more than six months before study enrolment * discharged to their home following inpatient rehabilitation * reporting functional impairments in the upper extremity that affect functioning and participation in everyday life due to the latest stroke. * score at least 4 points on the Shoulder Abduction + Finger Extension (SAFE) measure. * adequate language skills and cognitive functioning to be able to understand intervention material, perform outcome assessments and co-operate throughout the intervention * willing to participate and able to provide written consent * consent for participation also by closest family members, if they live in the same household Exclusion Criteria: * presence of other neurological conditions * reported limited life expectancy due to other medical conditions during the study period * severe mental health disorders, including substance use disorders * a history of violence * severe communication and/or cognition deficits (MoCA below 10 points) that prevent participants from being able to participate in the intervention, understand interview questions, or study-related instructions * unwillingness of persons sharing the household to participate and accept the intervention * uncontrolled medical issues such as unstable angina, severe hypertension, or severely limiting orthopaedic conditions

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Screened Participants

Timeframe: Post-acute recruitment phase through hospital stay (up to 6 months)

Number of Invited/Number of Accepted Participants

Timeframe: Post-acute recruitment phase through hospital stay (up to 6 months)

Number of Eligible Participants

Timeframe: Post-acute recruitment phase through hospital stay (up to 6 months)

Recruitment Rate

Timeframe: From enrolment to the start of participation in Week 1 (Preparation)

Retention Rate

Timeframe: 3 months after the intervention period (Weeks 2-6)

Completion of first-week study tasks and data collection

Timeframe: At the end of Week 1 (Preparation)

Completion and delivery of intervention

Timeframe: At the end of the Week 6 (Intervention)

Trial details

NCT IDNCT07517120

SponsorNorwegian School of Sport Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-01-31

Contact for this trial

James R Rudd, Professor

+47 46767926 jamesr@nih.no

View on ClinicalTrials.gov More Stroke trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Screened Participants

Timeframe: Post-acute recruitment phase through hospital stay (up to 6 months)

Number of Invited/Number of Accepted Participants

Timeframe: Post-acute recruitment phase through hospital stay (up to 6 months)

Number of Eligible Participants

Timeframe: Post-acute recruitment phase through hospital stay (up to 6 months)

Recruitment Rate

Timeframe: From enrolment to the start of participation in Week 1 (Preparation)

Retention Rate

Timeframe: 3 months after the intervention period (Weeks 2-6)

Completion of first-week study tasks and data collection

Timeframe: At the end of Week 1 (Preparation)

Completion and delivery of intervention

Timeframe: At the end of the Week 6 (Intervention)